RAND CAPITAL CORP
RANDAnalytical Summary
RAND CAPITAL CORP shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
20-Year Financial Trajectory
QuarterlyHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) | N/M | N/M | N/M | N/M |
-46.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
343.5%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
188.5%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
-35.7%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
223.1%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
-46.5%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | N/M | — | — | — | — | — | — | — |
| Net Income Growth YoY (%) | N/M | N/M | N/M | N/M |
-39.9%
Weak
↓
Weak
Declining
Year-over-year change in net income |
N/M |
342.7%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
189.6%
Excellent
↑
Excellent
Improving
Year-over-year change in net income |
-35.5%
Weak
↓
Weak
Declining
Year-over-year change in net income |
240.1%
Excellent
Excellent
Year-over-year change in net income |
-46.1%
Weak
Weak
Year-over-year change in net income |
N/M | N/M | — | — | — | — | — | — | — |
| FCF Growth YoY (%) | N/M | — | — | — | N/M | — | — | — |
-9.7%
Weak
Weak
Year-over-year change in free cash flow |
— | N/M |
355.4%
Excellent
Excellent
Year-over-year change in free cash flow |
N/M | — | — | — | — | — | — | — |
| EPS CAGR 3Y (%) | — |
43.0%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
9.57x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.54x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.66x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.04x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
9.19x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.27x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-3.46x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.97x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-12.31x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.67x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-2.03x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.86x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.32x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.52x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.37x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-0.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.1%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-4.2%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-13.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-4.5%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.7%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
11.3%
Fair
↑
Fair
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.3%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.0%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
4.4%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
3.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-3.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt (USD) | $-330.55K | $-4.21M | — | — | — | $-834.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Equity (USD) | $50.95M | $52.18M | $53.62M | $56.71M | $65.31M | $65.33M | $70.45M | $68.56M | $61.57M | $60.82M | $61.35M | $61.40M | $59.38M | $57.72M | $58.38M | $57.66M | $60.75M | $60.75M | $46.10M | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ | Q4 FY2019 May 20, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Expense (USD) | $6.25K | $6.25K | $6.25K | $6.25K | $6.25K | $6.25K | — | — | $6.25K | $6.25K | $6.25K | $6.25K | $6.25K | $6.25K | — | — | — | — | — | — |
| Net Income, GAAP (USD) | $-367.47K | $1.09M | $-2.23M | $-7.74M | $841.45K | $-2.95M | $2.64M | $7.74M | $1.40M | $1.09M | $595.50K | $2.67M | $2.17M | $320.18K | $1.10M | $-1.90M | $-410.54K | — | — | — |
| Operating Cash Flow (USD) | $-3.52M | $-2.76M | $5.93M | $347.69K | $7.73M | $782.07K | — | — | $-4.84M | $-1.06M | $-7.33M | $4.46M | $-4.41M | $-1.24M | $358.46K | $979.51K | $150.07K | — | — | — |
Secondary lens
Benchmark Lens
Compare RAND against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare RAND against peers after checking the statement evidence.
Percentile Rankings
How RAND compares to all companies
Compare RAND with peers
Stack RAND against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 7 years · 20 quarters